Concomitant Vaccination With the Japanese Encephalitis Vaccine IC51 and HARVIX® 1440

Clinical trial NCT00596271 · COMPLETED

Trial details

NCT number: NCT00596271
Sponsor: Valneva Austria GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Japanese Encephalitis

Start date: 2005-09-01
Primary completion: 2006-07-01
Enrollment: 192

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.